Related Experiment Video
Updated: Jun 19, 2026

07:53
Three-Dimensional Reconstruction for the Whole Lung with Early Multiple Pulmonary Nodules
Published on: October 13, 2023
Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence
Cristina Marrocchio1, Michele Ligorio, Nicola Sverzellati
1Unit of Radiological Sciences, University Hospital of Parma, University of Parma, Parma, Italy.
Current Opinion in Pulmonary Medicine
|June 18, 2026
Summary
Quantitative imaging and artificial intelligence (AI) show promise in diagnosing and assessing interstitial lung diseases (ILD). While AI improves accuracy and prognostication, its widespread clinical use in ILD is still developing.
Area of Science:
- Pulmonary Medicine
- Radiology
- Medical Imaging
Background:
- Interstitial lung diseases (ILD) are a heterogeneous group of disorders affecting the lung parenchyma.
- Accurate diagnosis and prognostication of ILD are crucial for patient management.
- Quantitative imaging techniques and artificial intelligence (AI) offer new avenues for ILD assessment.
Purpose of the Study:
- To review recent advancements in quantitative imaging and AI applications for interstitial lung diseases (ILD).
- To explore the evolving role of AI in the diagnosis, characterization, quantification, and prognostication of fibrotic ILD.
Main Methods:
- Review of recent technical developments in quantitative imaging.
- Analysis of current AI algorithms applied to chest imaging in ILD.
- Synthesis of evidence on AI performance in ILD diagnosis, characterization, quantification, and prognostication.
Main Results:
- AI algorithms in chest imaging demonstrate improved performance over previous methods.
- AI applications show potential in enhancing ILD diagnosis, characterization, quantification, and prognostication.
- Quantitative CT and AI improve visual assessment, sensitivity, and inter-observer agreement in ILD.
Conclusions:
- Quantitative CT and AI tools show significant utility in improving ILD assessment and prognostic stratification.
- Evidence supports the integration of these technologies for a broader range of ILD.
- Routine clinical implementation of quantitative imaging and AI in ILD management is currently limited but progressing.

